For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220804:nRSD8523Ua&default-theme=true
RNS Number : 8523U Alkemy Capital Investments PLC 04 August 2022
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR
FORM ANY PART OF AN OFFER TO SELL OR ISSUE, OR A SOLICITATION OF AN OFFER TO
BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY SECURITIES IN THE UNITED STATES,
AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN
WHICH SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL OR TO ANY PERSON TO WHOM IT
IS UNLAWFUL TO MAKE SUCH OFFER OR SOLICITATION. NO PUBLIC OFFERING OF THE
FUNDRAISE SHARES IS BEING MADE IN ANY SUCH JURISDICTION. ANY FAILURE TO COMPLY
WITH THESE RESTRICTIONS MAY CONSTITUTE A VIOLATION OF THE SECURITIES LAWS OF
SUCH JURISDICTIONS.
THIS ANNOUNCEMENT IS NOT FOR PUBLIC RELEASE, PUBLICATION OR DISTRIBUTION, IN
WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES,
AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN
WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE
MARKET ABUSE REGULATION NO. 596/2014 ("MAR") AS IN FORCE IN THE UNITED KINGDOM
PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF
THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE
PUBLIC DOMAIN.
4 August 2022
Alkemy Capital Investments Plc
Oversubscribed Placing to raise £1,200,000 and Directors Purchase of Shares
Alkemy Capital Investments plc ("Alkemy") (LSE: ALK) and its wholly owned
subsidiary Tees Valley Lithium Ltd ("TVL") are pleased to announce the
following corporate update.
Highlights:
· £1,200,000 new funds, before expenses, raised by Alkemy from new and
existing shareholders through a placing of 1,200,000 new ordinary shares at
£1 per share.
· £178,000 of these new shares are being subscribed for by Directors,
showing strong support.
Fundraise and Director Purchase of Shares
Alkemy is pleased to announce that it has raised £1,200,000 in an
oversubscribed placing of 1,200,000 new ordinary shares at a placing price
of £1 per share.
This includes cash subscriptions of £178,000 from the directors, including
Paul Atherley (£78,000), Sam Quinn (£75,000) and Helen Pein (£25,000).
The net proceeds will be used to further fastrack the development of TVL's
lithium hydroxide processing faclility in Teesside, UK and for general working
capital purposes.
Following the placing, the directors will have the following beneficial
shareholdings in the Company:
Number of Shares % of enlarged capital
Paul Atherley (Chairman) 3,078,000 42.75%
Sam Quinn (Director) 325,000 4.51%
Helen Pein (Director) 25,000 0.35%
An application will be made for 1,200,000 Ordinary Shares to be admitted to
the official list (Standard Segment) and to trading on the Main Market of the
London Stock Exchange ("Admission") and Admission is expected to occur at 8.00
a.m. on 9 August 2022.
In accordance with the FCA's Disclosure Guidance and Transparency Rules, the
Company confirms that following Admission, the Company's enlarged issued
ordinary share capital will comprise 7,199,999 Ordinary Shares each with a
right to vote and with no shares held in treasury. Therefore, following
Admission, the above figure may be used by shareholders in the Company as the
denominator for the calculations to determine if they are required to notify
their interest in, or a change to their interest in the Company, under the
FCA's Disclosure Guidance and Transparency Rules.
Grant of Share Options
The Company also announces the proposed grant of 590,000 share options at £1
per share, for a period of 5 years, to further align Directors and senior
management with shareholders. A further announcement will be made once the
options have been granted.
Alkemy and TVL Director, Sam Quinn, commented:
"We are grateful to all the existing and new shareholders who have contributed
to this fundraise, which will help enable the further fast-tracked development
of TVL's lithium hydroxide processing facility in Teesside, UK. Funds will be
used to commence and advance FEED and to complete the planning process. We
appreciate the ongoing support from all stakeholders and look forward to a
successful year ahead as we move to establish the UK's first major independent
and sustainable lithium hydroxide producer at the Wilton International
Chemicals Park in Teesside, UK".
Further information
For further information, please visit the Company's website:
www.alkemycapital.co.uk (http://www.alkemycapital.co.uk) or
www.teesvalleylithium.co.uk (http://www.teesvalleylithium.co.uk)
-Ends-
Alkemy Capital Investments Plc Tel: 0207 317 0636
Sam Quinn info@alkemycapital.co.uk (mailto:info@alkemycapital.co.uk)
Buchanan Tel: 0207 466 5000
Bobby Morse/Abigail Gilchrist TVL@buchanan.uk.com
VSA Capital Limited Tel: 0203 005 5000
Andrew Monk (corporate broking) amonk@vsacapital.com (mailto:amonk@vsacapital.com)
Andrew Raca (corporate finance) araca@vsacapital.com (mailto:araca@vsacapital.com)
Shard Capital Partners LLP
Damon Heath Tel: 0207 186 9952
damon.heath@shardcapital.com (mailto:damon.heath@shardcapital.com)
Isabella Pierre Tel: 0207 186 9927
isabella.pierre@shardcapital.com (mailto:isabella.pierre@shardcapital.com)
NOTES TO EDITORS
Alkemy is seeking to develop, construct and operate the world's leading
independent and sustainable lithium hydroxide production facility.
Alkemy, through its wholly-owned subsidiary Tees Valley Lithium, has secured
exclusivity to negotiate an option to lease over a 9.6ha brownfields site at
the Wilton International Chemicals Park located in Teesside, a major UK
Freeport.
Alkemy has completed a Class 4 Feasibility Study for its proposed lithium
hydroxide facility to process feedstock imported from various sources to
produce 96,000 tonnes of premium, low-carbon lithium hydroxide annually,
representing around 15% of Europe's projected demand.
Forward Looking Statements
This news release contains forward‐looking information. The statements are
based on reasonable assumptions and expectations of management and Alkemy
provides no assurance that actual events will meet management's expectations.
In certain cases, forward‐looking information may be identified by such
terms as "anticipates", "believes", "could", "estimates", "expects", "may",
"shall", "will", or "would". Although Alkemy believes the expectations
expressed in such forward‐looking statements are based on reasonable
assumptions, such statements are not guarantees of future performance and
actual results or developments may differ materially from those projected. In
addition, factors that could cause actual events to differ materially from the
forward-looking information stated herein include any factors which affect
decisions as to how to develop the project, process the materials and exercise
the option in respect of the lease, which may include changes in market
conditions, changes in metal prices, general economic and political
conditions, environmental risks, and community and non-governmental actions.
Such factors will also affect whether Alkemy will ultimately receive the
benefits anticipated pursuant to relevant agreements. This list is not
exhaustive of the factors that may affect any of the forward‐looking
statements. These and other factors should be considered carefully and readers
should not place undue reliance on forward-looking information.
The Notification of Dealing Form provided in accordance with the requirements
of the Market Abuse Regulation in relation to the transaction listed above is
set out below.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Paul Atherley
2 Reason for the notification
a) Position/status Chairman
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Alkemy Capital Investments PLC
b) LEI 213800NW5GVIRMXSRL48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares
Identification code GB00BMD6C023
b) Nature of the transaction Subscription of shares
c) Price(s) and volume(s)
Price(s) Volume(s)
£1.00 78,000
d) Aggregated information
- Aggregated volume 78,000
- Price £78,000
e) Date of the transaction 03/08/2022
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Sam Quinn
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Alkemy Capital Investments PLC
b) LEI 213800NW5GVIRMXSRL48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares
Identification code GB00BMD6C023
b) Nature of the transaction Subscription of shares
c) Price(s) and volume(s)
Price(s) Volume(s)
£1.00 75,000
d) Aggregated information
- Aggregated volume 75,000
- Price £75,000
e) Date of the transaction 03/08/2022
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Helen Pein
2 Reason for the notification
a) Position/status Non-ExecutIve Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Alkemy Capital Investments PLC
b) LEI 213800NW5GVIRMXSRL48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares
Identification code GB00BMD6C023
b) Nature of the transaction Subscription of shares
c) Price(s) and volume(s)
Price(s) Volume(s)
£1.00 25,000
d) Aggregated information
- Aggregated volume 25,000
- Price £25,000
e) Date of the transaction 03/08/2022
f) Place of the transaction Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOEFLFSATAIVIIF